Gilead Sciences (United States)

152.4k citations
4.0k papers ·

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
  • Virology top 0.5%
    • HIV Research and Treatment

Papers in

Gilead Sciences (United States)

3.5k papers receiving 137.9k citations

Peers

Gilead Sciences (United States)
Comparison fields: 5 of 221
  • Hepatology 27.4k
  • Virology 16.8k
  • Infectious Diseases 42.1k
  • Epidemiology 43.0k
  • Emergency Medicine 5.8k
Replace New Frontier with:
New Frontier United States
Scripps Clinic United States
The Lundquist Institute United States
City Of Hope National Medical Center United States
Roche (United States) United States
Amgen (United States) United States
City of Hope United States
UCLA Jonsson Comprehensive Cancer Center United States
Ronald Reagan UCLA Medical Center United States
USC Norris Comprehensive Cancer Center United States
Gilead Sciences (United States) relative to New Frontier United States New Frontier's profile →
Citations per field
00.5×10×12.9×
New Frontier · 1×
Citations per year

Countries citing scholars working at Gilead Sciences (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Gilead Sciences (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Gilead Sciences (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilead Sciences (United States) more than expected).

Fields of papers published by authors at Gilead Sciences (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Gilead Sciences (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Gilead Sciences (United States) at the time of their publication.

About Gilead Sciences (United States)

In recent decades, authors affiliated with Gilead Sciences (United States) have published 4.0k papers, which have received a total of 152.4k indexed citations . Scholars at this organization have produced 382 papers in Virology, 597 papers in Hepatology, 1.1k papers in Infectious Diseases, 314 papers in Genetics and 844 papers in Epidemiology on the topics of HIV/AIDS drug development and treatment (776 papers), Hepatitis C virus research (537 papers), Hepatitis B Virus Studies (416 papers), HIV Research and Treatment (378 papers), HIV/AIDS Research and Interventions (307 papers), Chronic Lymphocytic Leukemia Research (273 papers), Liver Disease Diagnosis and Treatment (228 papers) and HIV-related health complications and treatments (123 papers). Their work is cited by papers focused on Hepatology (27.4k citations), Virology (16.8k citations), Infectious Diseases (42.1k citations), Epidemiology (43.0k citations) and Emergency Medicine (5.8k citations). Authors at Gilead Sciences (United States) collaborate with scholars in United States, United Kingdom and France and have published in prestigious journals including Journal of Hepatology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Blood and JAIDS Journal of Acquired Immune Deficiency Syndromes. Some of Gilead Sciences (United States)'s most productive authors include Tomáš Cihlář, Robert G. Strickley, Richard W. Wagner, Adrian S. Ray, Michael D. Miller, John G. McHutchison, Joy Y. Feng, Brian P. Kearney, Kenneth C. Cundy and Luiz Belardinelli.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact